A Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2339345.

NCT01587716 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Cough

Interventions

DRUG: GSK2339345 (Inhaled) Single Dose
OTHER: Placebo (Inhaled) Single Dose
DRUG: GSK2339345 (Inhaled) Repeat Dose
OTHER: Placebo (Inhaled) Repeat Dose

Sponsor

GlaxoSmithKline